Arkolith/Insider Trading/LBPH/Form 4

Lind Kevin Robert

CEO, DirectorLongboard Pharmaceuticals, Inc. (LBPH) · full profile →Form 4 · filed Aug 13, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2024Option exercise(M)80K$3.12$250K429K
Aug 12, 2024Option exercise(M)2K$4.20$9K431K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2024Option exercise(M)80K—$0268K
Aug 12, 2024Option exercise(M)2K—$0193K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-096499) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML